NovoCure Ltd (NAS:NVCR)
$ 23.15 0.84 (3.77%) Market Cap: 2.49 Bil Enterprise Value: 2.13 Bil PE Ratio: 0 PB Ratio: 6.68 GF Score: 60/100

Q1 2021 Novocure Ltd Earnings Call Transcript

Apr 29, 2021 / 12:00PM GMT
Release Date Price: $205.31 (-0.09%)
Operator

Good day, and thank you for standing by. Welcome to the NovoCure First Quarter 2021 Earnings Conference. (Operator Instructions)

I would now like to hand the conference over to your speaker today, Adam Daney.

Adam Daney

Good morning, everyone, and thank you for joining us to review NovoCure's first quarter 2021 performance.

I'm joined on the phone by our Executive Chairman, Bill Doyle; our CEO, Asaf Danziger; and our CFO, Ashley Cordova. Other members of our executive leadership team are also on the call and available for Q&A.

The slides presented today can be viewed on our website, www.novocure.com, by clicking on the link of the first quarter 2021 financial results located in the Events section of our Investor Relations page.

Before we start, I would like to remind you that our discussion during this conference call will include forward-looking statements, and actual results could differ materially from those projected in these statements. These statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot